Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-24 @ 2:12 PM
Study NCT ID:
NCT01918995
Status:
COMPLETED
Last Update Posted:
2013-08-30
First Post:
2013-08-06
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-06
First Submit QC Date:
None
Study First Post Date:
2013-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-28
Last Update Post Date:
2013-08-30
Last Update Post Date Type:
ESTIMATED